Influencia de la pérdida de peso en paciente con obesidad para la reversión de la esteatosis hepática no alcohólica

Abstract

Abstract: Hepatic steatosis represents a global health problem, affecting progressively to the population, generally accompanied by health problems overweight and obesity. Therefore, it can be taken as a therapeutic measure weight loss, which is why this review focuses on whether weight loss weight influences the reversal of non-alcoholic hepatic steatosis in patients with obesity. To do this, articles were searched according to MeSH terms, mainly in PubMed, selected original articles published in the last 5 years. It was found that weight loss positively influences reversal of non-alcoholic hepatic steatosis, either with changes in the style of life, pharmacological measures or surgical interventions. Which indicates that the Weight loss can be considered as a therapeutic measure for steatosis hepatic. The long-term results of interventions should be investigated higher quality diets and studies in Latin America.